Skip to main content
OpenTrials
Completed

NCT Number: NCT03109275

Connectome Characterization With Aging

The main aim of this project is to develop a new model to characterize brain connectivity and its changes with aging. This characterization will be based on new sensitive and specific markers, allowing a better understanding of structural and functional brain networks. To this end, two complementary MRI methods will be developed: 1) Resting-state functional MRI (rs-fMRI) which allows the measurement of cerebral activity in different cortical gray matter regions, and 2) high angular resolution diffusion imaging (HARDI) MRI, which allows to characterize brain tissue microarchitecture. HARDI sequences will be developed to acquire and reconstruct fiber tractography of patient's brains. In combination with conventional MRI, both HARDI and rs-fMRI will be used to estimate the connection degree between each pair of cortical regions, so- called "Connectome". Once generated, brain networks will be quantified through numerous graph metrics, such as graph density, global efficiency and assortativity (etc.), reflecting the organization and topology of subjects' connectivity with aging.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CH le Vinatier

Bron, 69500, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Volunteers (Men and women) aged between 18 and 50 years
  • No neurological or psychiatric diseases

Exclusion criteria

  • MRI contraindications
  • Pregnant women or nursing women
  • Persons under guardianship or any other administrative or deprivation of liberty or of right

Treatment and study plan

Single complete MRI intervention

Other

MRI examination will comprise conventional T1 and FLAIR sequences, and advanced sequences such as rs-fMRI and High angular resolution MRI (HARDI).

Primary outcomes

  1. Functional and structural connectivity MRI marker : resting-state fMRI

    Time frame: End of study (one year)

    Functional connectivity of grey matter (GM) using resting-state fMRI

  2. Functional and structural connectivity MRI marker : Functional connectivity

    Time frame: End of study (one year)

    Graph-theory methods analysis of functional connectivity of grey matter

  3. Functional and structural connectivity MRI marker : Diffusion tensor

    Time frame: End of study (one year)

    Structural connectivity of white matter (WM) fiber bundles measured by diffusion tensor imaging

  4. Functional and structural connectivity MRI marker : Structural connectivity

    Time frame: End of study (one year)

    Graph-theory methods analysis of Structural connectivity of white matter (WM) fiber

  5. Functional and structural connectivity MRI marker : SPM software

    Time frame: End of study (one year)

    Cortical and subcortical grey matter (GM) volumes using the SPM software

Secondary outcomes

  1. Metrics of functional connectivity

    Time frame: End of study (one year)

    Calculation of functional connectivity metrics using graphs theory methods

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

Connectome Characterization With Aging Using Functional and Structural MRI

Acronym: AGE-CONNECT

Important dates

Study start
2016
Primary completion
2020
Study completion
2020
First posted
Apr 12, 2017
Registry last updated
Oct 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.